logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 15 of 15 Items
Showing 1 - 15 of 15 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Attrition from care among men initiating ART in male-only clinics compared with men in general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis

Cassidy T, Cornell M, Makeleni B, Horsburgh CR, Trivino Duran L,  et al.
2022-07-31 • AIDS and Behavior
2022-07-31 • AIDS and Behavior
Men have higher rates of attrition from antiretroviral therapy (ART) programs than women. In Khayelitsha, a high HIV prevalence area in South Africa, two public sector primary healthcare...
Journal Article
|
Research

'I didn't know so many people cared about me': support for patients who interrupt drug-resistant TB treatment

Snyman L, Venables E, Trivino Duran L, Mohr E, Azevedo VD,  et al.
2018-09-01 • International Journal of Tuberculosis and Lung Disease
2018-09-01 • International Journal of Tuberculosis and Lung Disease
SETTING
Early interventions for patients who interrupt their treatment for drug-resistant tuberculosis (DR-TB) are rarely reported and assessed. A novel, patient-centred intervention...
Journal Article
|
Research

Attrition from HIV care among youth initiating ART in youth-only clinics compared with general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis

Cassidy T, Cornell M, Runeyi P, Dutyulwa T, Kilani C,  et al.
2022-01-25 • Journal of the International AIDS Society
2022-01-25 • Journal of the International AIDS Society
INTRODUCTION
Youth living with HIV (YLWH) are less likely to initiate antiretroviral therapy (ART) and remain in care than older adults. It is important to identify effective strate...
Journal Article
|
Commentary

How COVID-19 could benefit tuberculosis and HIV services in South Africa

Keene CM, Mohr-Holland E, Cassidy T, Scott V, Nelson AM,  et al.
2020-09-01 • Lancet Respiratory Medicine
2020-09-01 • Lancet Respiratory Medicine
Journal Article
|
Letter

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients

Mohr-Holland E, Daniels J, Douglas-Jones B, Mema N, Scott V,  et al.
2021-05-01 • International Journal of Tuberculosis and Lung Disease
2021-05-01 • International Journal of Tuberculosis and Lung Disease
Journal Article
|
Commentary

Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB

Cox V, McKenna L, Acquah R, Reuter A, Wasserman S,  et al.
2020-11-01 • International Journal of Tuberculosis and Lung Disease
2020-11-01 • International Journal of Tuberculosis and Lung Disease
Rapid diagnostics, newer drugs, repurposed medications, and shorter regimens have radically altered the landscape for treating rifampicin-resistant TB (RR-TB) and multidrug-resistant TB ...
Journal Article
|
Research

Feasibility of using teleradiology to improve tuberculosis screening and case management in a district hospital in Malawi

Coulborn RM, Panunzi I, Spijker S, Brant WE, Trivino Duran L,  et al.
2012-06-21 • Bulletin of the World Health Organization
2012-06-21 • Bulletin of the World Health Organization
Malawi has one of the world's highest rates of human immunodeficiency virus (HIV) infection (10.6%), and southern Malawi, where Thyolo district is located, bears the highest burden in th...
Journal Article
|
Research

Time to embrace access programmes for medicines: Lessons from the South African flucytosine access programme

Shroufi A, Govender NP, Meintjes GA, Black JM, Nel J,  et al.
2020-06-01 • International Journal of Infectious Diseases
2020-06-01 • International Journal of Infectious Diseases
BACKGROUND
Cryptococcal Meningitis (CM) is estimated to cause 181,000 deaths annually; with the majority occurring in Sub Saharan Africa. Flucytosine is recommended by the World Heal...
Journal Article
|
Research

"Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa

Mohr E, Snyman L, Mbakaz Z, Caldwell J, De Azevedo V,  et al.
2018-09-14 • PLOS One
2018-09-14 • PLOS One
BACKGROUND
Self-administered treatment (SAT), a differentiated model of care for rifampicin-resistant tuberculosis (RR-TB), might address adherence challenges faced by patients and h...
Journal Article
|
Research

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa

Mohr-Holland E, Reuter A, Furin J, Garcia-Prats AJ, De Azevedo V,  et al.
2020-03-01 • eClinicalMedicine
2020-03-01 • eClinicalMedicine
BACKGROUND
Limited data exist on the use of bedaquiline and delamanid in adolescents with rifampicin-resistant tuberculosis (RR-TB). We describe RR-TB treatment of adolescents (10-19...
Journal Article
|
Research

Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study

Mashau RC, Meiring ST, Quan VC, Nel J, Greene GS,  et al.
2022-06-21 • Lancet Infectious Diseases
2022-06-21 • Lancet Infectious Diseases
BACKGROUND
Although flucytosine is a key component of WHO-recommended induction treatment for HIV-associated cryptococcal meningitis, this antifungal agent is not widely available in...
Journal Article
|
Research

Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa

Mohr E, Hughes J, Reuter A, Trivino Duran L, Ferlazzo G,  et al.
2018-05-03 • European Respiratory Journal
2018-05-03 • European Respiratory Journal
Experience with delamanid (Dlm) is limited, particularly among HIV-positive individuals. We describe early efficacy and safety data from a programmatic setting in South Africa. This was ...
Journal Article
|
Letter

Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa"

Mohr-Holland E, Reuter A, Hughes J, Daniels J, Beko B,  et al.
2020-07-01 • European Respiratory Journal
2020-07-01 • European Respiratory Journal
Journal Article
|
Research

HIV Testing and Retention in Care of Infants Born to HIV- Infected Women Enrolled in 'Option B+', Thyolo, Malawi

Martínez Pérez G, Metcalf CJ, Garone DB, Coulborn RM, Harries AD,  et al.
2014-06-21 • Public Health Action
2014-06-21 • Public Health Action
Prevention of mother-to-child transmission 'Option B+' originated in Malawi in 2011 to prevent new infections in infants exposed to the human immunodeficiency virus (HIV). We assessed 12...
Journal Article
|
Commentary

Barriers and solutions to finding rifampicin-resistant tuberculosis cases in older children and adolescents

Mohr-Holland E, Apolisi I, Reuter A, De Azevedo V, Hill JE,  et al.
2019-12-21 • Public Health Action
2019-12-21 • Public Health Action
Little is known about the barriers to post-exposure management of rifampicin-resistant tuberculosis (RR-TB) in older children and adolescents. We report on implementation lessons from a ...